WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Stock

$128.12+0.75 (+0.59%)
Updated Feb 21, 2024
MRK Price
$128.12
Fair Value Price
N/A
Market Cap
$324.66B
52 Week Low
$99.14
52 Week High
$129.29
P/E
70.78x
P/B
7.87x
P/S
4.4x
PEG
0.87x
Dividend Yield
2.31%
Revenue
$59.31B
Earnings
$4.61B
Gross Margin
72.9%
Operating Margin
14.34%
Profit Margin
7.8%
Debt to Equity
1.59
Operating Cash Flow
$17B
Beta
0.51
Next Earnings
N/A
Ex-Dividend
Mar 14, 2024
Next Dividend
Apr 5, 2024

MRK Overview

Merck & Company Incorporated develops and distributes prescription medicines, vaccines, biologic therapies, and animal health products. Merck & Co. was founded in 1891 and is headquartered in Kenilworth, NJ.

Zen Score

Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRK ($128.12) is trading above its intrinsic value of $61.40, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MRK is poor value based on its earnings relative to its share price (70.78x), compared to the US market average (28.8x)
P/E vs Market Valuation
MRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MRK due diligence checks available for Premium users.

Be the first to know about important MRK news, forecast changes, insider trades & much more!

MRK News

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
70.78x
Industry
55.46x
Market
28.8x
MRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MRK is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.87x
Industry
5.87x
MRK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential
MRK is good value based... subscribe to Premium to read more.
PEG Value Valuation

MRK's financial health

Profit margin

Revenue
$16.0B
Net Income
$4.7B
Profit Margin
29.7%
MRK's Earnings (EBIT) of $8.51B... subscribe to Premium to read more.
Interest Coverage Financials
MRK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$106.7B
Liabilities
$65.4B
Debt to equity
1.59
MRK's short-term assets ($31.95B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRK's long-term liabilities ($42.33B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MRK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$7.7B
Investing
-$334.0M
Financing
-$4.3B
MRK's operating cash flow ($17.19B)... subscribe to Premium to read more.
Debt Coverage Financials

MRK vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
MRK$324.66B+0.59%70.78x7.87x
ABBV$309.38B-0.35%64.15x29.86x
JNJ$382.22B+0.52%11.43x5.56x
NVS$209.64B-0.16%14.34x4.49x
AZN$201.80B+0.08%33.90x5.16x

Merck & Co Stock FAQ

What is Merck & Co's quote symbol?

(NYSE: MRK) Merck & Co trades on the NYSE under the ticker symbol MRK. Merck & Co stock quotes can also be displayed as NYSE: MRK.

If you're new to stock investing, here's how to buy Merck & Co stock.

What is the 52 week high and low for Merck & Co (NYSE: MRK)?

(NYSE: MRK) Merck & Co's 52-week high was $129.29, and its 52-week low was $99.14. It is currently -0.9% from its 52-week high and 29.23% from its 52-week low.

How much is Merck & Co stock worth today?

(NYSE: MRK) Merck & Co currently has 2,534,023,084 outstanding shares. With Merck & Co stock trading at $128.12 per share, the total value of Merck & Co stock (market capitalization) is $324.66B.

Merck & Co stock was originally listed at a price of $53.00 in Dec 31, 1997. If you had invested in Merck & Co stock at $53.00, your return over the last 26 years would have been 141.74%, for an annualized return of 3.45% (not including any dividends or dividend reinvestments).

How much is Merck & Co's stock price per share?

(NYSE: MRK) Merck & Co stock price per share is $128.12 today (as of Feb 21, 2024).

What is Merck & Co's Market Cap?

(NYSE: MRK) Merck & Co's market cap is $324.66B, as of Feb 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merck & Co's market cap is calculated by multiplying MRK's current stock price of $128.12 by MRK's total outstanding shares of 2,534,023,084.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.